Novo Holdings acquires 60% stake in Single Use Support to bolster biopharma innovations
In a strategic move to enhance its presence in the biopharmaceutical sector, Novo Holdings A/S has secured a majority stake of approximately 60% in Single Use Support, a pioneering Austrian company specializing in bioprocessing solutions. The acquisition underscores Novo Holdings’ commitment to advancing healthcare technologies and marks its first control investment in the DACH region, […]